MedTrace Logo

Safety and Efficacy of an Amino Acid Blend on Muscle and Gut Functionality in ICU Patients

NCT02968836 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2022-05-02

No results posted yet for this study

Summary

Assessment of the Safety and efficacy of an amino acid blend on muscle and gut functionality in Intensive Care Unit (ICU) patients.

Since this was a proof of concept, exploratory trial, we assessed different primary outcomes without hierarchy.

Conditions

  • Enteral Nutrition

Interventions

DIETARY_SUPPLEMENT

Blend of amino acids

The product was poured in bottles containing the enteral nutrition that the patient received as standard of care.

DIETARY_SUPPLEMENT

Maltodextrin only

The product was poured in bottles containing the enteral nutrition that the patient received as standard of care.

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Djillali Annane, Pr · Raymond Poincaré Hospital, Garches, France

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2019-09-30
Completion
2019-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02968836 on ClinicalTrials.gov